Tonix Pharmaceuticals Holding (TNXP) Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Current Assets for 17 years, with the latest figure at $203.4 million in Q2 2026.

• On a quarterly basis, Current Assets rose 41.73% year-over-year to $203.4 million in Q2 2026; TTM through Jun 2026 was $203.4 million, a 41.73% increase from a year earlier, with the FY2025 full-year figure at $228.9 million, up 92.33% from the prior year.
• Current Assets was $203.4 million for Q2 2026 at Tonix Pharmaceuticals Holding, down from $207.2 million in the prior quarter.
• The five-year high for Current Assets was $228.9 million in Q4 2025, with the low at $25.3 million in Q2 2024.
• Average Current Assets over 5 years is $122.6 million, with a median of $137.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Assets slumped 79.27% in 2023, then surged 467.62% in 2025.
• Over 5 years, Current Assets stood at $130.8 million in 2022, then plunged by 63.47% to $47.8 million in 2023, then surged by 149.12% to $119.0 million in 2024, then surged by 92.33% to $228.9 million in 2025, then decreased by 11.12% to $203.4 million in 2026.
• The last three Current Assets figures came in at $203.4 million (Q2 2026), $207.2 million (Q1 2026), and $228.9 million (Q4 2025), per Business Quant data.